Dr. Gabriel W Wurdeman, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 120 W Osage St, Sedan, KS 67361 Phone: 620-725-3122 Fax: 620-725-5395 |
Dr. Colin Michael Shawhan, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 120 W Osage St, Sedan, KS 67361 Phone: 620-725-3122 |
News Archive
The first patient has been enrolled in the phase I/II REPARO study, the first international clinical trial evaluating the ophthalmological use of a topical solution of recombinant human Nerve Growth Factor (rhNGF) for the treatment of moderate to severe neurotrophic keratitis (NK).
Pediatric cancer patients whose central lines are used to treat them at home develop three times as many dangerous bloodstream infections from their devices than their hospitalized counterparts, according to the results of a new Johns Hopkins Children's Center study.
Researchers from the European Molecular Biology Laboratory (EMBL) have discovered that proteins that regulate the body's iron household play a vital role in making sure enough nutrients and water are absorbed in the intestine.
EpiCept Corporation has announced that it has filed a New Drug Submission (NDS) with Health Canada for CepleneĀ® (histamine dihydrochloride) for the treatment of acute myeloid leukemia (AML) patients in first complete remission. Health Canada typically accepts or refuses an NDS and designates review status within forty-five days of filing. If accepted, the customary timeframe for completion of review and an approval decision is within one year.
› Verified 7 days ago